The impact of intraoperative opioid use on survival after oral cancer surgery.

[1]  Charles S. Coffey,et al.  Chronic Opioid Use Following Surgery for Oral Cavity Cancer , 2017, JAMA otolaryngology-- head & neck surgery.

[2]  C. Cernea,et al.  Tumor volume as an independent predictive factor of worse survival in patients with oral cavity squamous cell carcinoma , 2017, Head & neck.

[3]  B. Schmidt,et al.  Ex vivo nonviral gene delivery of &mgr;-opioid receptor to attenuate cancer-induced pain , 2017, Pain.

[4]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[5]  J. Cata,et al.  Intraoperative opioids use for laryngeal squamous cell carcinoma surgery and recurrence: a retrospective study. , 2015, Journal of clinical anesthesia.

[6]  F. Janku,et al.  The mu opioid receptor: A new target for cancer therapy? , 2015, Cancer.

[7]  N. Saba,et al.  Oral Cavity Cancer: Risk Factors, Pathology, and Management , 2015, Oncology.

[8]  E. Sharon,et al.  Exploiting the critical perioperative period to improve long-term cancer outcomes , 2015, Nature Reviews Clinical Oncology.

[9]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[10]  E. Li,et al.  Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma. , 2015, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[11]  R. Słotwiński,et al.  The immune response to surgery and infection , 2014, Central-European journal of immunology.

[12]  M. Motamedi,et al.  Opium Usage as an Etiologic Factor of Oral Cavity Cancer , 2014, The Journal of craniofacial surgery.

[13]  R. Salgia,et al.  Increased μ-opioid receptor expression in metastatic lung cancer. , 2014, British journal of anaesthesia.

[14]  J. Cata,et al.  A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection , 2014, Cancer medicine.

[15]  M. Kuskowski,et al.  Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer , 2013, Cancer.

[16]  R. Salgia,et al.  Overexpression of the &mgr;-Opioid Receptor in Human Non-Small Cell Lung Cancer Promotes Akt and mTOR Activation, Tumor Growth, and Metastasis , 2012, Anesthesiology.

[17]  B. Tombal,et al.  Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer? , 2011, European journal of anaesthesiology.

[18]  Chin-Tu Chen,et al.  The Novel Role of the Mu Opioid Receptor in Lung Cancer Progression: A Laboratory Investigation , 2011, Anesthesia and analgesia.

[19]  P. D. Dios,et al.  Oral cancer pain. , 2010, Oral oncology.

[20]  A. Negassa,et al.  Validation of the Histologic Risk Model in a New Cohort of Patients With Head and Neck Squamous Cell Carcinoma , 2010, The American journal of surgical pathology.

[21]  W. Mackillop,et al.  Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States , 2009, International journal of cancer.

[22]  M. Lingen,et al.  Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. , 2006, Microvascular research.

[23]  R. Hebbel,et al.  Opioids heal ischemic wounds in the rat , 2005, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[24]  A. Khamesipour,et al.  Opium and risk of laryngeal cancer , 2003, The Laryngoscope.

[25]  M. Okura,et al.  Prognostic significance of perioperative blood transfusion in oral cavity squamous cell carcinoma , 2003, Head & neck.

[26]  D. Yee,et al.  Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. , 2002, Cancer research.

[27]  Sabita Roy,et al.  The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the μ‐opioid receptor , 2002, Journal of leukocyte biology.

[28]  D. Locker,et al.  The role of diagnostic delays in the prognosis of oral cancer: a review of the literature. , 1998, Oral oncology.

[29]  B. Fuchs,et al.  A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity. , 1994, The Journal of pharmacology and experimental therapeutics.

[30]  M. Yeager,et al.  Perioperative immunomodulation in cancer surgery. , 1994, American journal of surgery.

[31]  R. Khoo.  Radiotherapy of carcinoma of the Larynx. , 1981, Annals of the Academy of Medicine, Singapore.